Skip to content

PCVX VAXCYTE INC

Follow

Stock (common), issuer CIK 1649094

Filings received so far for Q3 2026: 8 13F filers report a position in PCVX shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Wassil Jimofficer (EVP, Chief Scientific Ofc, COO)2026-10-05-18,000 S$86.74Form 4
Wassil Jimofficer (EVP, Chief Scientific Ofc, COO)2026-10-05+18,000 M$5.35Form 4
Cowan Elviaofficer (SVP, Finance & CAO)2026-10-05-19,000 S$86.74Form 4
Cowan Elviaofficer (SVP, Finance & CAO)2026-10-05+19,000 M$25.92Form 4

13F holders, Q3 2026

Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
GAMMA Investing LLC1,769$101K<0.01%+42213F-HRTimeline
Versant Capital Management, Inc754$42.9K<0.01%+113F-HRTimeline
MassMutual Private Wealth & Trust, FSB500$28.4K<0.01%-9713F-HRTimeline
Farther Finance Advisors, LLC470$26.7K<0.01%+7113F-HRTimeline
TOTH FINANCIAL ADVISORY CORP23$1.31K<0.01%new13F-HRTimeline
Trust Co10$569<0.01%013F-HRTimeline
CoreCap Advisors, LLC8$455<0.01%013F-HRTimeline
Planning Strategies Inc.4$228<0.01%+213F-HRTimeline

Events

  • Wassil Jim reported transactions in PCVX shares with no net change in a Form 4 filed 2026-10-07. 0001813798-26-000023

    Accepted , ingested
  • Cowan Elvia reported transactions in PCVX shares with no net change in a Form 4 filed 2026-10-07. 0001960048-26-000013

    Accepted , ingested